Skip to main content

Arrowhead Pharmaceuticals, Inc.

ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000879407

In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Arrowhead Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
311
+17 vs. Q3 2021
Shares held
68.0M
+1.42M (+2.1%) vs. Q3 2021
Total value
$4.51B
+$350.3M (+8.4%) vs. Q3 2021
New holders
50
104 more added
Sold out
33
111 more reduced

3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ARWR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 311 institutions
Q1 2021: 289 institutionsQ2 2021: 314 institutionsQ3 2021: 297 institutionsQ4 2021: 311 institutionsQ1 2022: 307 institutionsQ2 2022: 279 institutionsQ3 2022: 278 institutionsQ4 2022: 282 institutionsQ1 2023: 257 institutionsQ2 2023: 274 institutionsQ3 2023: 257 institutionsQ4 2023: 266 institutionsQ1 2024: 273 institutionsQ2 2024: 272 institutionsQ3 2024: 272 institutionsQ4 2024: 269 institutionsQ1 2025: 264 institutionsQ2 2025: 281 institutionsQ3 2025: 303 institutionsQ4 2025: 401 institutionsQ1 2026: 437 institutionsQ2 2026: 501 institutions
Value heldQ4 2021: $4.51B
Q1 2021: $4.55BQ2 2021: $5.54BQ3 2021: $4.16BQ4 2021: $4.51BQ1 2022: $3.19BQ2 2022: $2.54BQ3 2022: $2.35BQ4 2022: $2.97BQ1 2023: $1.85BQ2 2023: $2.57BQ3 2023: $2.01BQ4 2023: $2.37BQ1 2024: $2.76BQ2 2024: $2.54BQ3 2024: $1.90BQ4 2024: $1.88BQ1 2025: $1.34BQ2 2025: $1.67BQ3 2025: $3.83BQ4 2025: $7.70BQ1 2026: $7.58BQ2 2026: $9.73B
Institutions holding ARWR and their total value by quarter
QuarterHoldersValue
Q2 2026501$9.73B
Q1 2026437$7.58B
Q4 2025401$7.70B
Q3 2025303$3.83B
Q2 2025281$1.67B
Q1 2025264$1.34B
Q4 2024269$1.88B
Q3 2024272$1.90B
Q2 2024272$2.54B
Q1 2024273$2.76B
Q4 2023266$2.37B
Q3 2023257$2.01B
Q2 2023274$2.57B
Q1 2023257$1.85B
Q4 2022282$2.97B
Q3 2022278$2.35B
Q2 2022279$2.54B
Q1 2022307$3.19B
Q4 2021311$4.51B
Q3 2021297$4.16B
Q2 2021314$5.54B
Q1 2021289$4.55B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Arrowhead Pharmaceuticals, Inc.; share changes are against Q3 2021.

Institutions holding ARWR in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC1,366,377$90.6M0.01%+35,254+2.6%Added
Northern Trust Corp1,422,149$94.3M0.02%−21,802−1.5%Reduced
Geode Capital Management, LLC1,815,900$120.4M0.01%+25,523+1.4%Added
Invesco Ltd.2,305,641$152.9M0.04%−7,802−0.3%Reduced
Alliancebernstein L.P.2,464,511$163.4M0.06%+1,494,218+154.0%Added
JPMorgan Chase & Co2,979,064$197.5M0.02%+139,822+4.9%Added
Johnson & Johnson3,260,869$216.2M24.61%00.0%Unchanged
State Street Corp3,904,771$258.9M0.01%−26,397−0.7%Reduced
Vanguard Group Inc9,640,143$639.1M0.01%−3,7730.0%Reduced
BlackRock Inc.12,008,063$796.1M0.02%+66,218+0.6%Added
Sofos Investments, Inc.858––+850+10,625.0%Added
CastleArk Alternatives, LLC0$00.00%−73,960−100.0%Sold out
Renaissance Technologies LLC0$00.00%−54,100−100.0%Sold out
Fred Alger Management, LLC0$00.00%−41,803−100.0%Sold out
HRT Financial LP0$00.00%−33,301−100.0%Sold out
First Trust Advisors LP0$00.00%−28,754−100.0%Sold out
Capital Fund Management S.A.0$00.00%−23,970−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−20,300−100.0%Sold out
Natixis0$00.00%−19,486−100.0%Sold out
AlphaCrest Capital Management LLC0$00.00%−18,476−100.0%Sold out
Jefferies Group LLC0$00.00%−15,000−100.0%Sold out
SG3 Management, LLC0$00.00%−14,849−100.0%Sold out
Squarepoint Ops LLC0$00.00%−6,961−100.0%Sold out
Polaris Wealth Advisory Group, LLC0$00.00%−6,999−100.0%Sold out
Winton Group Ltd0$00.00%−6,030−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−4,366−100.0%Sold out
First Citizens Bank & Trust Co0$00.00%−4,124−100.0%Sold out
Meeder Asset Management Inc0$00.00%−3,760−100.0%Sold out
Means Investment Co., Inc.0$00.00%−3,730−100.0%Sold out
Baker Avenue Asset Management, LP0$00.00%−3,680−100.0%Sold out
Public Sector Pension Investment Board0$00.00%−3,503−100.0%Sold out
Centiva Capital, LP0$00.00%−3,300−100.0%Sold out
KBC Group NV0$00.00%−2,655−100.0%Sold out
Herold Advisors, Inc.0$00.00%−1,800−100.0%Sold out
Edmond de Rothschild Holding S.A.0$00.00%−1,525−100.0%Sold out
Harbour Investments, Inc.0$00.00%−1,040−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−694−100.0%Sold out
Whittier Trust Co0$00.00%−500−100.0%Sold out
Creative Financial Designs Inc0$00.00%−382−100.0%Sold out
Gerber Kawasaki Wealth & Investment Management0$00.00%−150−100.0%Sold out
Ibex Wealth Advisors0$00.00%−108−100.0%Sold out
Better Money Decisions, LLC0$00.00%−61−100.0%Sold out
Focused Wealth Management, Inc0$00.00%−17−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−8−100.0%Sold out
World Asset Management Inc––––Not filed
First Mercantile Trust Co––––Not filed
Berman Capital Advisors, LLC––––Not filed